These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15767844)

  • 21. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
    Hasegawa Y; Ono H
    Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats.
    Przegaliñski E; Filip M
    Behav Pharmacol; 1997 Dec; 8(8):699-706. PubMed ID: 9832955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist.
    Matuszewich L; Lorrain DS; Trujillo R; Dominguez J; Putnam SK; Hull EM
    Brain Res; 1999 Feb; 820(1-2):55-62. PubMed ID: 10023030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Behav Pharmacol; 2005 Nov; 16(7):543-52. PubMed ID: 16170231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules.
    Chiang TJ; Al-Ruwaitea AS; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Sep; 151(4):379-91. PubMed ID: 11026745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward.
    Fletcher PJ; Korth KM
    Psychopharmacology (Berl); 1999 Feb; 142(2):165-74. PubMed ID: 10102769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified adjusting delay task to assess impulsive choice between isocaloric reinforcers in non-deprived male rats: effects of 5-HT₂A/C and 5-HT₁A receptor agonists.
    Blasio A; Narayan AR; Kaminski BJ; Steardo L; Sabino V; Cottone P
    Psychopharmacology (Berl); 2012 Jan; 219(2):377-86. PubMed ID: 21989803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
    Body S; Cheung TH; Bezzina G; Asgari K; Fone KC; Glennon JC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2006 Dec; 189(3):331-43. PubMed ID: 17051415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic administration of 8-OH-DPAT and eticlopride, but not SCH23390, alters loss-chasing behavior in the rat.
    Rogers RD; Wong A; McKinnon C; Winstanley CA
    Neuropsychopharmacology; 2013 May; 38(6):1094-104. PubMed ID: 23303072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.
    Nakamura K; Kurasawa M
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):521-8. PubMed ID: 10832606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.
    Winstanley CA; Chudasama Y; Dalley JW; Theobald DE; Glennon JC; Robbins TW
    Psychopharmacology (Berl); 2003 May; 167(3):304-14. PubMed ID: 12677356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Kuroki T; Kitchen MT; Meltzer HY
    Eur J Pharmacol; 1995 Dec; 287(2):179-84. PubMed ID: 8749033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task.
    Zeeb FD; Robbins TW; Winstanley CA
    Neuropsychopharmacology; 2009 Sep; 34(10):2329-43. PubMed ID: 19536111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.